FDA Advisory Panel Set to Review COVID-19 Booster Doses
The FDA announced that an advisory committee will meet on September 17 to discuss the issue of booster doses of COVID-19 vaccines, according to a FirstWord report. The Vaccines and Related Biological Products Advisory Committee will specifically look at Pfizer/BioNTech’s recent submission seeking approval of a third dose of their vaccine Comirnaty to prevent COVID-19 in people 16 years and older.
Peter Marks, director of the FDA’s Center for Biologics Research and Evaluation, said “the administration recently announced a plan to prepare for additional COVID-19 vaccine doses…this fall, and a key part of that plan is FDA completing an independent evaluation and determination of the safety and effectiveness of these additional vaccine doses.” The broad rollout of booster vaccines is slated to get under way as of September 20.